Search research articles
Contact Us
Filters
Showing results (191-200 of 504) with videos related to
Page
of 51
Sort By:
Blood
|
July 15, 2005
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
Kensuke Kojima, Marina Konopleva, Ismael J Samudio, et al.
Cell Cycle (Georgetown, Tex.)
|
October 25, 2008
Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK
Alina Felicia Nica, Chun Chui Tsao, Julie C Watt, et al.
Plos One
|
June 28, 2007
Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma
Christina L Kress, Marina Konopleva, Vanesa Martínez-García, et al.
Cancer Research
|
April 19, 2005
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas
Akira Nakamizo, Frank Marini, Toshiyuki Amano, et al.
Investigational New Drugs
|
February 12, 2013
Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML)
Harry P Erba, Hamid Sayar, Mark Juckett, et al.
Cancer Research
|
February 1, 2013
TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells
Naoki Shinojima, Anwar Hossain, Tatsuya Takezaki, et al.
Plos One
|
November 14, 2013
Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells
Steven M Kornblau, Amina Qutub, Hui Yao, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 15, 2013
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia
Meir Wetzler, Debora A Thomas, Eunice S Wang, et al.
Cancer
|
February 25, 2003
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome
Jorge Cortes, Hagop Kantarjian, Maher Albitar, et al.
Cancer Research
|
December 20, 2007
Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment
Ann H Klopp, Erika L Spaeth, Jennifer L Dembinski, et al.
Page
of 51
Search research articles
Search
Showing results (191-200 of 504) with videos related to
Sort By:
Page
of 51
Blood
|
July 15, 2005
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
Kensuke Kojima, Marina Konopleva, Ismael J Samudio, et al.
Cell Cycle (Georgetown, Tex.)
|
October 25, 2008
Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK
Alina Felicia Nica, Chun Chui Tsao, Julie C Watt, et al.
Plos One
|
June 28, 2007
Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma
Christina L Kress, Marina Konopleva, Vanesa Martínez-García, et al.
Cancer Research
|
April 19, 2005
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas
Akira Nakamizo, Frank Marini, Toshiyuki Amano, et al.
Investigational New Drugs
|
February 12, 2013
Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML)
Harry P Erba, Hamid Sayar, Mark Juckett, et al.
Cancer Research
|
February 1, 2013
TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells
Naoki Shinojima, Anwar Hossain, Tatsuya Takezaki, et al.
Plos One
|
November 14, 2013
Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells
Steven M Kornblau, Amina Qutub, Hui Yao, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 15, 2013
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia
Meir Wetzler, Debora A Thomas, Eunice S Wang, et al.
Cancer
|
February 25, 2003
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome
Jorge Cortes, Hagop Kantarjian, Maher Albitar, et al.
Cancer Research
|
December 20, 2007
Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment
Ann H Klopp, Erika L Spaeth, Jennifer L Dembinski, et al.
Page
of 51